Austin ISD delayed a plan to redraw most of the district's zones, which impacts which schools students feed into, by a year.
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...
Topline results from Phase 3 EPCORE DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-fr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results